Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy

From January, 1995 till December, 2002 in Dnipropetrovsk a regional clinical oncological clinic have received treatment 345 patient sick by a cancer of bottom thirds of body and antral part of a stomach. From them 91 patient has been treated by the combined method with application of remote therap...

Full description

Saved in:
Bibliographic Details
Main Authors: Dumanskij Yu.V., Vlasenko D.L., Balashova O.I., Shponka I.S., Berdova D.L.
Format: Article
Language:English
Published: State Institution "Dnipro State Medical University" 2008-01-01
Series:Морфологія
Subjects:
Online Access:http://www.morphology.dp.ua/_pub/MORPHO-2008-02-01/08dyvplt.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839595395062169600
author Dumanskij Yu.V.
Vlasenko D.L.
Balashova O.I.
Shponka I.S.
Berdova D.L.
author_facet Dumanskij Yu.V.
Vlasenko D.L.
Balashova O.I.
Shponka I.S.
Berdova D.L.
author_sort Dumanskij Yu.V.
collection DOAJ
description From January, 1995 till December, 2002 in Dnipropetrovsk a regional clinical oncological clinic have received treatment 345 patient sick by a cancer of bottom thirds of body and antral part of a stomach. From them 91 patient has been treated by the combined method with application of remote therapy in a mode of an average fractioning of doze in neoadjuvant regimen. Radiotherapy was spent to patients with prevalence of tumoral process Т3N+M0 and Т4NхM0 at absence of contra-indications to carrying out of distant gamma-therapy (absolut stenosis of the gatekeeper, expressed astenia and an anemia, a bleeding from a tumour in the anamnesis). To patients with smaller prevalence of tumoral process surgical treatment was spent. In article the features of spent radiotherapy, its influence on current of tumoral process, results of surgical treatment of patients of both groups, parameters of medical pathomorphosis and their dependence on a degree of a differentiation of a tumour, parameters of lethality about one year are presented and given results of immunohistochemical researches of tumours biopsy of the patients who have received combined treatment. Also the probable interrelation between expression of НЕR-2/NEU and KI-67 with the received direct results of treatment is tracked.
format Article
id doaj-art-f0e5e360c8d94e509bb96f11a45de8bb
institution Matheson Library
issn 1997-9665
language English
publishDate 2008-01-01
publisher State Institution "Dnipro State Medical University"
record_format Article
series Морфологія
spelling doaj-art-f0e5e360c8d94e509bb96f11a45de8bb2025-08-02T23:07:38ZengState Institution "Dnipro State Medical University"Морфологія1997-96652008-01-01215156Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapyDumanskij Yu.V.Vlasenko D.L.Balashova O.I.Shponka I.S.Berdova D.L.From January, 1995 till December, 2002 in Dnipropetrovsk a regional clinical oncological clinic have received treatment 345 patient sick by a cancer of bottom thirds of body and antral part of a stomach. From them 91 patient has been treated by the combined method with application of remote therapy in a mode of an average fractioning of doze in neoadjuvant regimen. Radiotherapy was spent to patients with prevalence of tumoral process Т3N+M0 and Т4NхM0 at absence of contra-indications to carrying out of distant gamma-therapy (absolut stenosis of the gatekeeper, expressed astenia and an anemia, a bleeding from a tumour in the anamnesis). To patients with smaller prevalence of tumoral process surgical treatment was spent. In article the features of spent radiotherapy, its influence on current of tumoral process, results of surgical treatment of patients of both groups, parameters of medical pathomorphosis and their dependence on a degree of a differentiation of a tumour, parameters of lethality about one year are presented and given results of immunohistochemical researches of tumours biopsy of the patients who have received combined treatment. Also the probable interrelation between expression of НЕR-2/NEU and KI-67 with the received direct results of treatment is tracked.http://www.morphology.dp.ua/_pub/MORPHO-2008-02-01/08dyvplt.pdfa cancer of a stomachoperative treatmentneoadjuvant radiotherapyimmunohistochemical researchdirect results of treatment
spellingShingle Dumanskij Yu.V.
Vlasenko D.L.
Balashova O.I.
Shponka I.S.
Berdova D.L.
Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
Морфологія
a cancer of a stomach
operative treatment
neoadjuvant radiotherapy
immunohistochemical research
direct results of treatment
title Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
title_full Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
title_fullStr Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
title_full_unstemmed Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
title_short Possibility of using НЕR-2/NEU & KI-67, as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
title_sort possibility of using неr 2 neu ki 67 as prognostic factors of distal stomach tumor answer for neoadjuvant therapy
topic a cancer of a stomach
operative treatment
neoadjuvant radiotherapy
immunohistochemical research
direct results of treatment
url http://www.morphology.dp.ua/_pub/MORPHO-2008-02-01/08dyvplt.pdf
work_keys_str_mv AT dumanskijyuv possibilityofusingner2neuki67asprognosticfactorsofdistalstomachtumoranswerforneoadjuvanttherapy
AT vlasenkodl possibilityofusingner2neuki67asprognosticfactorsofdistalstomachtumoranswerforneoadjuvanttherapy
AT balashovaoi possibilityofusingner2neuki67asprognosticfactorsofdistalstomachtumoranswerforneoadjuvanttherapy
AT shponkais possibilityofusingner2neuki67asprognosticfactorsofdistalstomachtumoranswerforneoadjuvanttherapy
AT berdovadl possibilityofusingner2neuki67asprognosticfactorsofdistalstomachtumoranswerforneoadjuvanttherapy